ClinicalTrials.gov record
Phase 4 COPD and Suboptimal Inspiratory Flow Rate
ClinicalTrials.gov ID: NCT05165485
Public ClinicalTrials.gov record NCT05165485. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 4, Randomized, Double-Blind, Double-Dummy, Parallel-Group, Study Comparing Improvements in Lung Function in Adults With Severe to Very Severe Chronic Obstructive Pulmonary Disease and Suboptimal Inspiratory Flow Rate Following Once-Daily Treatment Over 12 Weeks With Either Revefenacin Inhalation Solution Delivered Via Standard Jet Nebulizer or Tiotropium Delivered Via a Dry Powder Inhaler (Spiriva® HandiHaler®)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Study is a randomized, double-blind, double-dummy, parallel-group study evaluating efficacy and safety of revefenacin vs. tiotropium in adults with severe to very severe COPD and suboptimal PIFR.
Study identification
- NCT ID
- NCT05165485
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 404 participants
Conditions and interventions
Conditions
Interventions
- Revefenacin Drug
- Tiotropium Drug
- Revefenacin Placebo Drug
- Tiotropium Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 6, 2022
- Primary completion
- Nov 12, 2023
- Completion
- Nov 19, 2023
- Last update posted
- Dec 19, 2024
2022 – 2023
United States locations
- U.S. sites
- 76
- U.S. states
- 25
- U.S. cities
- 70
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Theravance Biopharma Investigational Site | Jasper | Alabama | 35501 | — |
| Theravance Biopharma Investigational Site | Phoenix | Arizona | 85018 | — |
| Theravance Biopharma Investigational Site | Tucson | Arizona | 85715 | — |
| Theravance Biopharma Investigational Site | Newport Beach | California | 92663 | — |
| Theravance Biopharma Investigational Site | San Diego | California | 92120 | — |
| Theravance Biopharma Investigational Site | Stockton | California | 95207 | — |
| Theravance Biopharma Investigational Site | Upland | California | 91786 | — |
| Theravance Biopharma Investigational Site | Lakewood | Colorado | 80228 | — |
| Theravance Biopharma Investigational Site | Brandon | Florida | 33511 | — |
| Theravance Biopharma Investigational Site | Clearwater | Florida | 33756 | — |
| Theravance Biopharma Investigational Site site 2 | Clearwater | Florida | 33765 | — |
| Theravance Biopharma Investigational Site | Clearwater | Florida | 33765 | — |
| Theravance Biopharma Investigational Site | Daytona Beach | Florida | 32117 | — |
| Theravance Biopharma Investigational Site | Leesburg | Florida | 34748 | — |
| Theravance Biopharma Investigational Site | Miami | Florida | 33155 | — |
| Theravance Biopharma Investigational Site | Miami | Florida | 33186 | — |
| Theravance Biopharma Investigational Site | Orlando | Florida | 32825 | — |
| Theravance Biopharma Investigational Site | Ormond Beach | Florida | 32174 | — |
| Theravance Biopharma Investigational Site | Sarasota | Florida | 34239 | — |
| Theravance Biopharma Investigational Site | Tampa | Florida | 33606 | — |
| Theravance Biopharma Investigational Site | Winter Park | Florida | 32789 | — |
| Theravance Biopharma Investigational Site | Chicago Ridge | Illinois | 60415 | — |
| Theravance Biopharma Investigational Site | River Forest | Illinois | 60305 | — |
| Theravance Biopharma Investigational Site | Hammond | Indiana | 46324 | — |
| Theravance Biopharma Investigational Site | Valparaiso | Indiana | 46383 | — |
| Theravance Biopharma Investigational Site | Annapolis | Maryland | 21401 | — |
| Theravance Biopharma Investigational Site | Columbia | Maryland | 21046 | — |
| Theravance Biopharma Investigational Site | Oxon Hill | Maryland | 20745 | — |
| Theravance Biopharma Investigational Site | Towson | Maryland | 21286 | — |
| Theravance Biopharma Investigational Site | North Dartmouth | Massachusetts | 02747 | — |
| Theravance Biopharma Investigational Site | Farmington Hills | Michigan | 48336 | — |
| Theravance Biopharma Investigational Site | Saint Charles | Missouri | 63301 | — |
| Theravance Biopharma Investigational Site | St Louis | Missouri | 63141 | — |
| Theravance Biopharma Investigational Site | Missoula | Montana | 59808 | — |
| Theravance Biopharma Investigational Site | Las Vegas | Nevada | 89106 | — |
| Theravance Biopharma Investigational Site | Albuquerque | New Mexico | 87108 | — |
| Theravance Biopharma Investigational Site | Bronxville | New York | 10708 | — |
| Theravance Biopharma Investigational Site | Schenectady | New York | 12308 | — |
| Theravance Biopharma Investigational Site | Charlotte | North Carolina | 28207 | — |
| Theravance Biopharma Investigational Site | Hickory | North Carolina | 28601 | — |
| Theravance Biopharma Investigational Site | Huntersville | North Carolina | 28078 | — |
| Theravance Biopharma Investigational Site | Kernersville | North Carolina | 27284 | — |
| Theravance Biopharma Investigational Site | Monroe | North Carolina | 28112 | — |
| Theravance Biopharma Investigational Site | Raleigh | North Carolina | 27607 | — |
| Theravance Biopharma Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| Theravance Biopharma Investigational Site | Cincinnati | Ohio | 45236 | — |
| Theravance Biopharma Investigational Site | Cincinnati | Ohio | 45242 | — |
| Theravance Biopharma Investigational Site | Columbus | Ohio | 43215 | — |
| Theravance Biopharma Investigational Site | Columbus | Ohio | 43235 | — |
| Theravance Biopharma Investigational Site | Marion | Ohio | 43302 | — |
| Theravance Biopharma Investigational Site | Grants Pass | Oregon | 97527 | — |
| Theravance Biopharma Investigational Site | Medford | Oregon | 97504 | — |
| Theravance Biopharma Investigational Site | Portland | Oregon | 97202 | — |
| Theravance Biopharma Investigational Site | Anderson | South Carolina | 29621 | — |
| Theravance Biopharma Investigational Site | Columbia | South Carolina | 29204 | — |
| Theravance Biopharma Investigational Site | Gaffney | South Carolina | 29340 | — |
| Theravance Biopharma Investigational Site | Greenville | South Carolina | 29615 | — |
| Theravance Biopharma Investigational Site | Lexington | South Carolina | 29072 | — |
| Theravance Biopharma Investigational Site | North Charleston | South Carolina | 29406 | — |
| Theravance Biopharma Investigational Site | Rock Hill | South Carolina | 29732 | — |
| Theravance Biopharma Investigational Site #2 | Spartanburg | South Carolina | 29303 | — |
| Theravance Biopharma Investigational Site | Spartanburg | South Carolina | 29303 | — |
| Theravance Biopharma Investigational Site | Union | South Carolina | 29379 | — |
| Theravance Biopharma Investigational Site | Franklin | Tennessee | 37067 | — |
| Theravance Biopharma Investigational Site | Johnson City | Tennessee | 37601 | — |
| Theravance Biopharma Investigational Site | Knoxville | Tennessee | 37909 | — |
| Theravance Biopharma Investigational Site | Kerrville | Texas | 78028 | — |
| Theravance Biopharma Investigational Site | McAllen | Texas | 78503 | — |
| Theravance Biopharma Investigational Site | San Antonio | Texas | 78229 | — |
| Theravance Biopharma Investigational Site | Sherman | Texas | 75092 | — |
| Theravance Biopharma Investigational Site | Webster | Texas | 77598 | — |
| Theravance Biopharma Investigational Site | Roy | Utah | 84067 | — |
| Theravance Biopharma Investigational Site | West Valley City | Utah | 84120 | — |
| Theravance Biopharma Investigational Site | Abingdon | Virginia | 24210 | — |
| Theravance Biopharma Investigational Site | Spokane | Washington | 99204 | — |
| Theravance Biopharma Investigational Site | Cudahy | Wisconsin | 53110 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05165485, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 19, 2024 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05165485 live on ClinicalTrials.gov.